Streetbeat News

Products Services

BLK

BTCUSD

Bitcoin (BTC) and the crypto market have been on the rise over the past two weeks, with BTC trading at its yearly highs. The rally was sparked by the news of BlackRock's upcoming BTC ETF, which caused a spike of over 10% in BTC's price. The price has held even after the ETF was removed from the Depository Trust and Clearing Corporation’s (DTCC) website. Some traders/investors are considering BTC as a hedge against falling financial markets.

Portfolio Pulse from Thrash Capital

October 30, 2023 | 9:37 pm

SIEN

Sientra is exploring strategic alternatives to improve its balance sheet and ensure continued success. The company is experiencing growth in the breast reconstruction market with new products like Viality and SimpliDerm, despite softness in the augmentation market. Sientra aims to enhance its financial position to become a preferred partner for plastic surgeons.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 9:09 pm

PINS

Pinterest CEO, Bill Ready, stated in a conference call that artificial intelligence (AI) has been a significant source of strength for the company.

Portfolio Pulse from Charles Gross

October 30, 2023 | 9:09 pm

BIOR

Biora Therapeutics, Inc. (NASDAQ:BIOR) has submitted an updated Investigational New Drug (IND) application for BT-600 to the U.S. Food and Drug Administration (FDA). The update includes additional clarifying information and provides additional time for regulatory review. The IND application for BT-600 includes extensive manufacturing, preclinical, human device function, and toxicology data to support a first-in-human clinical trial for BT-600, a drug/device combination designed to use Biora's NaviCap™ ingestible drug delivery device with a proprietary liquid formulation of tofacitinib for the treatment of moderate to severe ulcerative colitis.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 8:57 pm

JACK

Jack in the Box Inc. (NASDAQ:JACK) has opened its first store in Louisville, marking its entry into the Kentucky market. This is the second new market entry in the past three months, following Salt Lake City. The company also announced a new agreement with a group of veteran franchisees to open six new restaurants in the Louisville market. The new location features the brand's innovative CRAVED image and offers dine-in, drive-thru, mobile ordering options, and will be open 24 hours per day.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 8:55 pm

INTC

JBL

Jabil Inc. has agreed to take over the manufacture and sale of Intel's silicon photonics transceiver product lines. The deal is expected to allow Intel to focus on its core business while Jabil expands its product portfolio.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 8:54 pm

LIAN

LianBio (NASDAQ:LIAN) has announced positive topline results from the Phase 3 LIBRA clinical trial of TP-03 in Chinese patients with Demodex blepharitis. The trial showed statistically significant mite eradication in patients treated with TP-03. The company plans to discuss these results with the China National Medical Products Administration (NMPA) and expects to use the data to support a New Drug Application filing in China.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 8:54 pm

ANVS

Annovis Bio, Inc. (NYSE:ANVS) has received a positive safety review from the Data and Safety Monitoring Board (DSMB) for its phase 2/3 trial of buntanetap, a drug candidate for moderate to mild Alzheimer's Disease patients. The DSMB recommended that Annovis Bio continue the trial as originally designed. The trial of buntanetap was initiated in late March 2023 and to date, 281 patients have been recruited out of the planned 320. In phase 2 trials, buntanetap was observed to improve cognition and speed of thinking.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 8:46 pm

CHGG

Chegg Inc reported Q3 results with revenue of $157.9 million, beating the consensus estimate of $152.67 million, and adjusted earnings of 18 cents per share, beating analyst estimates of 17 cents per share. However, subscription services revenues and subscribers fell 4% and 8% YoY respectively. The company also announced the rollout of its new AI-powered user experience. For Q4, Chegg expects revenue between $185 million and $187 million, and subscription services revenues between $164 million and $166 million.

Portfolio Pulse from Adam Eckert

October 30, 2023 | 8:43 pm

SRPT

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced topline results from EMBARK, a Phase 3 clinical study of ELEVIDYS in patients with Duchenne muscular dystrophy. The results showed statistically significant results on all key pre-specified secondary endpoints, demonstrating evidence of a clinically meaningful treatment benefit. The US FDA has indicated openness to reviewing the data for label expansion. Sarepta plans to host an investor call on October 30.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 8:06 pm